vs

Side-by-side financial comparison of Backblaze, Inc. (BLZE) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $37.8M, roughly 1.3× Backblaze, Inc.). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -14.3%, a 9.6% gap on every dollar of revenue. On growth, Backblaze, Inc. posted the faster year-over-year revenue change (11.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $9.0M). Over the past eight quarters, Backblaze, Inc.'s revenue compounded faster (12.3% CAGR vs -20.2%).

Backblaze, Inc. is an American cloud storage and data backup company based in San Mateo, California. It was founded in 2007 by Gleb Budman and others. Its services are intended for both business and personal markets.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

BLZE vs IRWD — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.3× larger
IRWD
$47.7M
$37.8M
BLZE
Growing faster (revenue YoY)
BLZE
BLZE
+59.1% gap
BLZE
11.8%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
9.6% more per $
IRWD
-4.8%
-14.3%
BLZE
More free cash flow
IRWD
IRWD
$65.5M more FCF
IRWD
$74.6M
$9.0M
BLZE
Faster 2-yr revenue CAGR
BLZE
BLZE
Annualised
BLZE
12.3%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLZE
BLZE
IRWD
IRWD
Revenue
$37.8M
$47.7M
Net Profit
$-5.4M
$-2.3M
Gross Margin
62.0%
Operating Margin
-12.4%
14.3%
Net Margin
-14.3%
-4.8%
Revenue YoY
11.8%
-47.3%
Net Profit YoY
62.3%
-200.9%
EPS (diluted)
$-0.09
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLZE
BLZE
IRWD
IRWD
Q4 25
$37.8M
$47.7M
Q3 25
$37.2M
$122.1M
Q2 25
$36.3M
$85.2M
Q1 25
$34.6M
$41.1M
Q4 24
$33.8M
$90.5M
Q3 24
$32.6M
$91.6M
Q2 24
$31.3M
$94.4M
Q1 24
$30.0M
$74.9M
Net Profit
BLZE
BLZE
IRWD
IRWD
Q4 25
$-5.4M
$-2.3M
Q3 25
$-3.8M
$40.1M
Q2 25
$-7.1M
$23.6M
Q1 25
$-9.3M
$-37.4M
Q4 24
$-14.4M
$2.3M
Q3 24
$-12.8M
$3.6M
Q2 24
$-10.3M
$-860.0K
Q1 24
$-11.1M
$-4.2M
Gross Margin
BLZE
BLZE
IRWD
IRWD
Q4 25
62.0%
Q3 25
62.1%
Q2 25
63.5%
Q1 25
55.6%
Q4 24
54.8%
Q3 24
54.6%
Q2 24
55.1%
Q1 24
52.8%
Operating Margin
BLZE
BLZE
IRWD
IRWD
Q4 25
-12.4%
14.3%
Q3 25
-8.9%
61.8%
Q2 25
-18.5%
53.2%
Q1 25
-25.8%
-70.7%
Q4 24
-40.8%
34.8%
Q3 24
-37.4%
28.0%
Q2 24
-31.4%
26.5%
Q1 24
-35.1%
14.7%
Net Margin
BLZE
BLZE
IRWD
IRWD
Q4 25
-14.3%
-4.8%
Q3 25
-10.2%
32.8%
Q2 25
-19.6%
27.7%
Q1 25
-26.9%
-90.9%
Q4 24
-42.6%
2.5%
Q3 24
-39.1%
4.0%
Q2 24
-33.1%
-0.9%
Q1 24
-36.9%
-5.6%
EPS (diluted)
BLZE
BLZE
IRWD
IRWD
Q4 25
$-0.09
$0.01
Q3 25
$-0.07
$0.23
Q2 25
$-0.13
$0.14
Q1 25
$-0.17
$-0.23
Q4 24
$-0.30
$0.03
Q3 24
$-0.29
$0.02
Q2 24
$-0.25
$-0.01
Q1 24
$-0.27
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLZE
BLZE
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$51.4M
$215.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$83.2M
$-261.8M
Total Assets
$191.8M
$396.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLZE
BLZE
IRWD
IRWD
Q4 25
$51.4M
$215.5M
Q3 25
$50.3M
$140.4M
Q2 25
$50.5M
$92.9M
Q1 25
$53.2M
$108.5M
Q4 24
$54.9M
$88.6M
Q3 24
$20.9M
$88.2M
Q2 24
$23.6M
$105.5M
Q1 24
$28.2M
$121.5M
Total Debt
BLZE
BLZE
IRWD
IRWD
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
BLZE
BLZE
IRWD
IRWD
Q4 25
$83.2M
$-261.8M
Q3 25
$82.8M
$-264.2M
Q2 25
$79.6M
$-308.2M
Q1 25
$77.8M
$-334.1M
Q4 24
$77.6M
$-301.3M
Q3 24
$42.8M
$-311.3M
Q2 24
$45.1M
$-321.7M
Q1 24
$47.5M
$-330.5M
Total Assets
BLZE
BLZE
IRWD
IRWD
Q4 25
$191.8M
$396.9M
Q3 25
$191.5M
$396.1M
Q2 25
$186.0M
$342.9M
Q1 25
$170.2M
$327.2M
Q4 24
$168.6M
$350.9M
Q3 24
$136.2M
$389.5M
Q2 24
$127.8M
$395.6M
Q1 24
$131.9M
$438.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLZE
BLZE
IRWD
IRWD
Operating Cash FlowLast quarter
$9.3M
$74.6M
Free Cash FlowOCF − Capex
$9.0M
$74.6M
FCF MarginFCF / Revenue
24.0%
156.3%
Capex IntensityCapex / Revenue
0.7%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.9M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLZE
BLZE
IRWD
IRWD
Q4 25
$9.3M
$74.6M
Q3 25
$5.7M
$47.6M
Q2 25
$3.5M
$-15.1M
Q1 25
$4.9M
$20.0M
Q4 24
$2.2M
$15.2M
Q3 24
$4.6M
$9.9M
Q2 24
$2.2M
$33.5M
Q1 24
$3.4M
$45.0M
Free Cash Flow
BLZE
BLZE
IRWD
IRWD
Q4 25
$9.0M
$74.6M
Q3 25
$2.6M
$47.6M
Q2 25
$2.8M
$-15.1M
Q1 25
$4.4M
$19.9M
Q4 24
$1.4M
Q3 24
$4.4M
$9.9M
Q2 24
$2.0M
$33.4M
Q1 24
$3.0M
$44.9M
FCF Margin
BLZE
BLZE
IRWD
IRWD
Q4 25
24.0%
156.3%
Q3 25
7.0%
39.0%
Q2 25
7.6%
-17.7%
Q1 25
12.8%
48.4%
Q4 24
4.2%
Q3 24
13.6%
10.8%
Q2 24
6.3%
35.4%
Q1 24
10.0%
60.0%
Capex Intensity
BLZE
BLZE
IRWD
IRWD
Q4 25
0.7%
0.0%
Q3 25
8.5%
0.0%
Q2 25
2.2%
0.0%
Q1 25
1.5%
0.1%
Q4 24
2.4%
0.0%
Q3 24
0.6%
0.0%
Q2 24
0.9%
0.1%
Q1 24
1.4%
0.1%
Cash Conversion
BLZE
BLZE
IRWD
IRWD
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons